Subacute sclerosing panencephalitis in South African children following the measles outbreak between 2009 and 2011.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 26428963)

Published in S Afr Med J on September 14, 2015

Authors

Edward Kija1, Alvin Ndondo, Graeme Spittal, Diana R Hardie, Brian Eley, Jo M Wilmshurst

Author Affiliations

1: Paediatric Neurology Unit, Department of Paediatrics and Child Health, Red Cross War Memorial Children's Hospital (RCWMCH) and Faculty of Health Sciences, University of Cape Town, South Africa. gertrude@hmpg.co.za.

Articles by these authors

Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study. Lancet Infect Dis (2011) 4.29

Outcomes of the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaboration. S Afr Med J (2009) 2.97

Challenges to pediatric HIV care and treatment in South Africa. J Infect Dis (2007) 2.76

Virologic failure and second-line antiretroviral therapy in children in South Africa--the IeDEA Southern Africa collaboration. J Acquir Immune Defic Syndr (2011) 2.39

Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa. J Acquir Immune Defic Syndr (2010) 2.21

Monitoring the South African National Antiretroviral Treatment Programme, 2003-2007: the IeDEA Southern Africa collaboration. S Afr Med J (2009) 2.17

Diagnosis of childhood tuberculosis and host RNA expression in Africa. N Engl J Med (2014) 2.12

Rapid molecular diagnosis of pulmonary tuberculosis in children using nasopharyngeal specimens. Clin Infect Dis (2012) 2.00

Detection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control study. PLoS Med (2013) 1.91

Culture-confirmed childhood tuberculosis in Cape Town, South Africa: a review of 596 cases. BMC Infect Dis (2007) 1.72

Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study. BMC Pediatr (2008) 1.70

Tuberculin skin test and in vitro assays provide complementary measures of antimycobacterial immunity in children and adolescents. Chest (2009) 1.68

Improved survival and antiretroviral treatment outcomes in adults receiving community-based adherence support: 5-year results from a multicentre cohort study in South Africa. J Acquir Immune Defic Syndr (2012) 1.46

Reconstitution of antimycobacterial immune responses in HIV-infected children receiving HAART. AIDS (2006) 1.40

Two loci control tuberculin skin test reactivity in an area hyperendemic for tuberculosis. J Exp Med (2009) 1.38

Temporal trends in baseline characteristics and treatment outcomes of children starting antiretroviral treatment: an analysis in four provinces in South Africa, 2004-2009. J Acquir Immune Defic Syndr (2011) 1.33

Comparison of T-SPOT.TB assay and tuberculin skin test for the evaluation of young children at high risk for tuberculosis in a community setting. Pediatrics (2009) 1.23

High heritability of antimycobacterial immunity in an area of hyperendemicity for tuberculosis disease. J Infect Dis (2010) 1.21

Lopinavir exposure is insufficient in children given double doses of lopinavir/ritonavir during rifampicin-based treatment for tuberculosis. Antivir Ther (2011) 1.17

The predictive value of cerebrospinal fluid Epstein-Barr viral load as a marker of primary central nervous system lymphoma in HIV-infected persons. J Clin Virol (2008) 1.12

p24 antigen rapid test for diagnosis of acute pediatric HIV infection. J Acquir Immune Defic Syndr (2010) 1.11

Novel human in vitro system for evaluating antimycobacterial vaccines. Infect Immun (2004) 1.10

Virologic response in children treated with abacavir-compared with stavudine-based antiretroviral treatment: a South African multi-cohort analysis. Pediatr Infect Dis J (2014) 1.09

Provision of antiretroviral therapy to children within the public sector of South Africa. Trans R Soc Trop Med Hyg (2008) 1.09

Variability of growth in children starting antiretroviral treatment in southern Africa. Pediatrics (2012) 1.08

Community adherence support improves programme retention in children on antiretroviral treatment: a multicentre cohort study in South Africa. J Int AIDS Soc (2012) 1.06

Accuracy of immunological criteria for identifying virological failure in children on antiretroviral therapy - the IeDEA Southern Africa Collaboration. Trop Med Int Health (2011) 1.05

Novel respiratory syncytial virus subtype ON1 among children, Cape Town, South Africa, 2012. Emerg Infect Dis (2013) 1.04

CD4 and CD8 T-cell responses to mycobacterial antigens in African children. Am J Respir Crit Care Med (2010) 1.04

Failure to control growth of mycobacteria in blood from children infected with human immunodeficiency virus and its relationship to T cell function. J Infect Dis (2003) 1.01

Seroprevalence of rubella antibodies among antenatal patients in the Western Cape. S Afr Med J (2005) 1.01

Effects of rifampin-based antituberculosis therapy on plasma efavirenz concentrations in children vary by CYP2B6 genotype. AIDS (2013) 0.94

Progressive multifocal leukoencephalopathy after initiation of highly active antiretroviral therapy in a child with advanced human immunodeficiency virus infection: a case of immune reconstitution inflammatory syndrome. Pediatr Infect Dis J (2004) 0.94

Enhanced anti-mycobacterial immunity in children with erythema nodosum and a positive tuberculin skin test. J Invest Dermatol (2007) 0.94

Reversion and conversion of Mycobacterium tuberculosis IFN-gamma ELISpot results during anti-tuberculous treatment in HIV-infected children. BMC Infect Dis (2010) 0.93

Progress of preventing mother-to-child transmission of HIV at primary healthcare facilities and district hospitals in three South African provinces. S Afr Med J (2012) 0.93

The clinical and molecular spectrum of galactosemia in patients from the Cape Town region of South Africa. BMC Pediatr (2002) 0.93

Increased vulnerability of rural children on antiretroviral therapy attending public health facilities in South Africa: a retrospective cohort study. J Int AIDS Soc (2010) 0.91

Treatment of sydenham chorea with intravenous immunoglobulin. J Child Neurol (2011) 0.91

Epidemiology of Staphylococcus aureus bacteraemia at a tertiary children's hospital in Cape Town, South Africa. PLoS One (2013) 0.91

Neurologic and neurobehavioral sequelae in children with human immunodeficiency virus (HIV-1) infection. J Child Neurol (2011) 0.90

Improved virological suppression in children on antiretroviral treatment receiving community-based adherence support: a multicentre cohort study from South Africa. AIDS Care (2013) 0.89

When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa. PLoS Med (2013) 0.89

Polymorphic variation in TIRAP is not associated with susceptibility to childhood TB but may determine susceptibility to TBM in some ethnic groups. PLoS One (2009) 0.88

An investigation into the prevalence and outcome of patients admitted to a pediatric intensive care unit with viral respiratory tract infections in Cape Town, South Africa. Pediatr Crit Care Med (2012) 0.88

Prognosis of children with HIV-1 infection starting antiretroviral therapy in Southern Africa: a collaborative analysis of treatment programs. Pediatr Infect Dis J (2014) 0.88

An update on the treatment of Sydenham's chorea: the evidence for established and evolving interventions. Ther Adv Neurol Disord (2010) 0.87

Incidence of AIDS-defining and Other Cancers in HIV-positive Children in South Africa: Record Linkage Study. Pediatr Infect Dis J (2016) 0.87

The role of targeted viral load testing in diagnosing virological failure in children on antiretroviral therapy with immunological failure. Trop Med Int Health (2012) 0.86

Giant congenital melanocytic nevi in a patient with brain structural malformations and multiple lipomatosis. J Child Neurol (2002) 0.85

Advances in childhood tuberculosis - contributions from the University of Cape Town. S Afr Med J (2012) 0.84

Specific neurologic complications of human immunodeficiency virus type 1 (HIV-1) infection in children. J Child Neurol (2006) 0.83

The diagnostic difficulties of complex glycerol kinase deficiency. J Child Neurol (2010) 0.83

Nutrition and HIV/AIDS in infants and children in South Africa: implications for food-based dietary guidelines. Matern Child Nutr (2007) 0.82

Outcomes of Infants Starting Antiretroviral Therapy in Southern Africa, 2004-2012. J Acquir Immune Defic Syndr (2015) 0.82

Addressing malnutrition in young children in South Africa. Setting the national context for paediatric food-based dietary guidelines. Matern Child Nutr (2007) 0.81

Low rates of hepatotoxicity in HIV-infected children on anti-retroviral therapy with and without isoniazid prophylaxis. J Trop Pediatr (2009) 0.81

RyR1 deficiency in congenital myopathies disrupts excitation-contraction coupling. Hum Mutat (2013) 0.81

Reducing CD4 Monitoring in Children on Antiretroviral Therapy With Virologic Suppression. Pediatr Infect Dis J (2015) 0.81

Viral load versus CD4⁺ monitoring and 5-year outcomes of antiretroviral therapy in HIV-positive children in Southern Africa: a cohort-based modelling study. AIDS (2014) 0.81

A novel ACTA1 mutation resulting in a severe congenital myopathy with nemaline bodies, intranuclear rods and type I fibre predominance. Neuromuscul Disord (2010) 0.81

Blood cultures in sick children. S Afr Med J (2013) 0.81

Oral trimethoprim-sulphamethoxazole levels in stable HIV-infected children. S Afr Med J (2006) 0.80

Prevalence of seizures in children infected with human immunodeficiency virus. J Child Neurol (2012) 0.80

The characteristics of juvenile myasthenia gravis among South Africans. S Afr Med J (2012) 0.79

Intellectual and behavioral functioning in a South african cohort of boys with duchenne muscular dystrophy. J Child Neurol (2011) 0.79

An innovative approach to improve the quality of prevention of mother-to-child transmission of HIV programs through nurse clinical mentoring in South Africa. J Acquir Immune Defic Syndr (2013) 0.78

Risk factors for invasive pneumococcal disease among children less than 5 years of age in a high HIV prevalence setting, South Africa, 2010 to 2012. Pediatr Infect Dis J (2015) 0.78

Gillespie syndrome: two further cases. J Child Neurol (2006) 0.78

Spinal muscular atrophy with congenital fractures: postmortem analysis. J Child Neurol (2002) 0.78

HIV viral load suppression in adults and children receiving antiretroviral therapy - results from the IeDEA collaboration. J Acquir Immune Defic Syndr (2017) 0.78

Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia. Clin Infect Dis (2016) 0.77

Hydatid disease of the spine in South African children. J Child Neurol (2003) 0.77

Acquired demyelinating disorders of childhood in the Western Cape, South Africa. J Child Neurol (2009) 0.77

CCL3L1 copy number, CCR5 genotype and susceptibility to tuberculosis. BMC Med Genet (2014) 0.77

Epilepsy South Africa: Turning obstacles into true potential. Epilepsia (2014) 0.76

Sydenham's chorea--clinical and therapeutic update 320 years down the line. S Afr Med J (2006) 0.76

Update on the key developments of the neurologic complications in children infected with HIV. Curr Opin HIV AIDS (2014) 0.76

Minimizing the risk of non-vertical, non-sexual HIV infection in children--beyond mother to child transmission. J Int AIDS Soc (2012) 0.76

Commentary: Reducing HIV-associated tuberculosis in children. Int J Epidemiol (2009) 0.75

Genetic testing for spinal muscular atrophy. S Afr Med J (2006) 0.75

Growth in Virologically Suppressed HIV-Positive Children on Antiretroviral Therapy: Individual and Population-level References. Pediatr Infect Dis J (2015) 0.75

The Keilah Foundation: making the ketogenic diet viable for children in Africa. Epilepsia (2014) 0.75

Markers of susceptibility to acute rheumatic fever: the B-cell antigen D8/17 is not robust as a marker in South Africa. Cardiol Young (2011) 0.75

Hemiatrophy of the spinal cord in a patient with mucopolysaccharidosis type IIIB. J Child Neurol (2010) 0.75

HIV-infected infants born to women who tested HIV-negative during pregnancy. S Afr Med J (2004) 0.75

Invasive carbapenem-resistant Enterobacteriaceae infection at a paediatric hospital: A case series. S Afr Med J (2016) 0.75

Clinical phenotype of South African children with neurofibromatosis 1. J Child Neurol (2006) 0.75

Emergence of vancomycin-resistant Enterococcus at a tertiary paediatric hospital in South Africa. S Afr Med J (2016) 0.75

Serologic diagnosis of congenital rubella: a cautionary tale. Pediatr Infect Dis J (2005) 0.75

Leaving the party -- withdrawal of South African essential medicines. S Afr Med J (2006) 0.75

Induction of tolerance after a serious trimethoprim-sulphamethoxazole reaction in an HIV-infected child. S Afr Med J (2003) 0.75

Congenital cervical spinal cord lesions: pathogenesis, management, and outcome. J Child Neurol (2007) 0.75

Access to parenteral phenobarbitone. S Afr Med J (2008) 0.75

Child neurology in Africa. Semin Pediatr Neurol (2014) 0.75